HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Nakaraang pagsara
$29.45
Sakop ng araw
$28.45 - $29.68
Sakop ng taon
$21.68 - $41.04
Market cap
5.50B USD
Average na Volume
2.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.73M | -33.22% |
Gastos sa pagpapatakbo | 189.26M | 17.62% |
Net na kita | -162.04M | 8.45% |
Net profit margin | -5.93K | -37.09% |
Kita sa bawat share | -1.08 | 0.54% |
EBITDA | -185.59M | -19.14% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 266.32M | -50.98% |
Kabuuang asset | 664.98M | 1.52% |
Kabuuang sagutin | 1.88B | 1.87% |
Kabuuang equity | -1.22B | — |
Natitirang share | 188.99M | — |
Presyo para makapag-book | -4.52 | — |
Return on assets | -64.11% | — |
Return on capital | -80.76% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -162.04M | 8.45% |
Cash mula sa mga operasyon | -180.57M | -24.33% |
Cash mula sa pag-invest | 38.23M | 1.44% |
Cash mula sa financing | 707.00K | -99.77% |
Net change in cash | -141.63M | -171.00% |
Malayang cash flow | -109.35M | -32.75% |
Tungkol
CEO
Itinatag
2015
Headquarters
Website
Mga Empleyado
553
